Suppr超能文献

非血管化腓骨骨移植中骨内种植体用于严重萎缩下颌骨重建的临床评估

Clinical evaluation of endosseous implants in nonvascularized fibula bone grafts for reconstruction of the severely atrophied mandibular bone.

作者信息

Nelson Katja, Glatzer Corvin, Hildebrand Detlef, Hell Berthold, Klein M

机构信息

Clinic for Oral and Maxillofacial Surgery and Clinical Navigation and Robotics, Charité Campus Virchow Clinic, Berlin, Germany.

出版信息

J Oral Maxillofac Surg. 2006 Sep;64(9):1427-32. doi: 10.1016/j.joms.2006.05.035.

Abstract

PURPOSE

The purpose of the present study was to assess changes in graft height after augmentation of the severely atrophied mandibula with the use of avascular fibula bone grafts, as well as evaluation of the clinical success of endosseous implants placed in the grafted mandibula.

PATIENTS AND METHODS

This retrospective study included 10 patients with a mean observation period of 31 months (range, 3 to 76 months). A total of 40 implants were placed. Clinical criteria included implant success, graft success, and crestal bone resorption.

RESULTS

The grafting procedure was successfully performed in all patients. All implants were integrated, 2 implants could not be used for prosthetic rehabilitation. One implant was lost 2 years after abutment connection. The maximum bone resorption of 7.21% (+/- 2.7%) was seen within the first year; no significant resorption was seen thereafter.

CONCLUSION

In this clinical and radiographic evaluation, it was found that nonvascular fibula graft is a reliable material for augmentation procedures. The resorption takes place within the first year after augmentation. The possibility of improving the clinical results in bone grafting situations with avascular fibula grafts will be further evaluated in a prospective follow-up study providing long-term assessment of this procedure.

摘要

目的

本研究的目的是评估使用无血管腓骨骨移植增加严重萎缩下颌骨后的移植高度变化,以及评估植入移植下颌骨的骨内种植体的临床成功率。

患者和方法

这项回顾性研究包括10名患者,平均观察期为31个月(范围为3至76个月)。共植入40颗种植体。临床标准包括种植体成功、移植成功和牙槽嵴骨吸收。

结果

所有患者的移植手术均成功完成。所有种植体均实现骨结合,2颗种植体无法用于修复重建。1颗种植体在连接基台2年后丢失。第一年的最大骨吸收为7.21%(±2.7%);此后未见明显吸收。

结论

在本次临床和影像学评估中,发现无血管腓骨移植是一种用于增量手术的可靠材料。吸收发生在增量后的第一年内。将在前瞻性随访研究中进一步评估使用无血管腓骨移植改善骨移植情况下临床结果的可能性,该研究将对该手术进行长期评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验